The market for impingement syndrome treatment is essentially impacted by the frequency and frequency paces of the condition. As a typical outer muscle problem, especially influencing the shoulder, impingement syndrome adds to a substantial patient populace, driving the interest for successful treatment choices.
Word related and way of life factors assume a pivotal part in the improvement of impingement syndrome. Occupations or exercises requiring monotonous above developments, like those in specific callings or sports, add to the risk of impingement syndrome. The market is affected by the requirement for preventive techniques and designated treatments for people with these risk factors.
Active recuperation and moderate methodologies are in many cases the first-line treatment for impingement syndrome. The market is molded by the accentuation on non-surgical mediations, including works out, stretches, and way of life changes, mirroring an inclination for negligibly obtrusive choices.
The utilization of nonsteroidal anti-inflammatory drugs (NSAIDs) to oversee agony and irritation is a typical part of impingement syndrome treatment. The market is impacted by the broad accessibility and utilization of NSAIDs, both over-the-counter and solution, as a component of the pharmacological management of side effects.
Corticosteroid infusions are every now and again utilized in the treatment of impingement syndrome, giving limited anti-inflammatory impacts. The market is influenced by the ubiquity of these infusions as a designated and viable mediation, with progressing research focused in on enhancing infusion conventions.
For cases impervious to moderate measures, arthroscopic medical procedure turns into a critical consider the market. Arthroscopic methods for impingement syndrome include insignificantly obtrusive strategies to resolve primary issues, offering diminished recuperation times and affecting treatment inclinations.
Arising regenerative medication draws near, like platelet-rich plasma (PRP) infusions and undeveloped cell treatment, are acquiring consideration in the impingement syndrome treatment market. These modalities plan to advance tissue mending and recovery, possibly offering options in contrast to customary mediations.
Report Attribute/Metric | Details |
---|---|
Growth Rate | Â Â 7.9% |
Impingement Syndrome Market Size was valued at USD 1.5 Billion in 2023. The Global Impingement Syndrome industry is projected to grow from USD 1.6 Billion in 2024 to USD 2.73 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.80% during the forecast period (2024 - 2032). Impingement syndrome or subacromial impingement occurs when the tendons of the rotator cuff muscles become impinged and inflamed as they pass through the subacromial space.
There are two major types of this disease, structural impingement and functional impingement. Different types of diagnosis methods like bone spurs, rotator cuff injury, labral injury, shoulder instability, biceps tendinopathy and scapula dysfunction can be used to diagnose this disorder. Increasing prevalence of orthopedic diseases, rising geriatric population and changing lifestyle have boosted the growth of the market. According to International Osteoporosis Foundation, worldwide osteoporosis causes more than 8.9 million fractures annually. Moreover, increasing healthcare expenditure and government initiatives for research and development have fuelled the market growth. However, high cost surgeries, and lack of awareness about this disorder may slow the growth of the market.
The global impingement syndrome market is segmented on the basis of types, diagnosis, treatment, and end users. On the basis of types, the market is segmented into structural impingement, and functional impingement.
On the basis of diagnosis, the market is segmented into physical examination, imaging, and other. Imaging is further segmented into ultrasonography, arthrography and MRI.
On the basis of treatment, the market is categorized into drug treatment, non-pharmacological treatment, and surgery. Drug treatment is further segmented into corticosteroid, local anesthetic, NSAIDs, and other. Non-pharmacological treatment is further segmented into joint mobilization, interferential therapy, acupuncture, soft tissue therapy, therapeutic taping, rotator cuff strengthening, and other. Surgery segment is subsegmented into arthroscopic surgery, open surgery and others. On the basis of end user, the market is segmented into hospitals, physical therapists, and others.
Some of the key players in this market are:
The America dominates the global impingement syndrome market owing to the presence of huge geriatric population, increasing number of patient suffering from orthopedic diseases and increasing healthcare expenditure. Moreover, high healthcare speeding is another major factor contributing to the market growth.
Europe accounts for the second largest impingement syndrome market across the globe owing to increasing government support for research & development, increasing investment in healthcare, and well developed healthcare sector.
Asia Pacific has the fastest growing market, increasing government support for research & development, increasing prevalence of chronic diseases, huge population base and rapidly developing economy drives the growth of the market in this region.
The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain.
Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)